Promising Results Suggest Gabapentin May Extend Survival in Glioblastoma Patients
A groundbreaking study conducted by researchers at Mass General Brigham has uncovered a potential breakthrough in the treatment of glioblastoma, the most aggressive and deadly type of brain cancer. Published in the prestigious journal Nature Communications, the research suggests that the commonly used pain-relieving medication gabapentin may significantly improve survival outcomes for patients diagnosed with this devastating disease.
Glioblastoma, often referred to as a